Study the Safety and Efficacy of Probiotics Use in Premature Infants

U

University of Manitoba

Status

Withdrawn

Conditions

Infant, Premature, Diseases

Treatments

Dietary Supplement: breast milk
Dietary Supplement: breast milk with Bifidobacterium Longum subp. Infantis R0033

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01891604
jamesfriel2013

Details and patient eligibility

About

Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm infants' health, and may also play a role in reducing NEC and associated morbidity.

Sex

All

Ages

Under 2 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • born with weight<1500 g
  • hospitalized within 48 hours after birth

Exclusion criteria

  • present with evidence or suspicion of congenital intestinal obstruction
  • perforation
  • gastroschisis
  • large omphalocele
  • congenital diaphragmatic hernia
  • major congenital heart defects

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems